The lower expression of FOXO1 implied an inferior OS for breast cancer patients (Fig. 2E), as well as a shortened recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) (Fig. S5B). The gene discussed is FOXO1; the disease is breast carcinoma.